The phantom of lactic acidosis due to metformin in patients with diabetes

被引:137
作者
Misbin, RI [1 ]
机构
[1] US FDA, Div Endocrinol & Metab, Rockville, MD 20851 USA
关键词
D O I
10.2337/diacare.27.7.1791
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Metformin rarely, if ever, causes lactic acidosis when it is used as labeled. Metformin is associated with lactic acidosis in patients with conditions that can themselves cause lactic acidosis (heart failure, hypoxia, sepsis, etc.). But it is impossible to determine to what extent, if any, metformin may contribute to the development of lactic acidosis in any individual case. When metformin is used as labeled, the increased risk of lactic acidosis is either zero or so close to zero that it cannot be factored into ordinary clinical decision making. That metformin can itself cause lactic acidosis is supported by the finding of lactic acidosis in people who took overdoses. Thus, the accumulation of metformin in the setting of renal insufficiency might be expected to precipitate lactic acidosis in some patients who are at risk. If one excludes overdoses, most cases of metformin-associated lactic acidosis, particularly the fatal ones, were probably not caused by metformin.
引用
收藏
页码:1791 / 1793
页数:3
相关论文
共 35 条
[1]   EPIDEMIOLOGY OF ADVERSE DRUG-REACTIONS TO PHENFORMIN AND METFORMIN [J].
BERGMAN, U ;
BOMAN, G ;
WIHOLM, BE .
BRITISH MEDICAL JOURNAL, 1978, 2 (6135) :464-466
[2]   Lactic acidosis rates in type 2 diabetes [J].
Brown, JB ;
Pedula, K ;
Barzilay, J ;
Herson, MK ;
Latare, P .
DIABETES CARE, 1998, 21 (10) :1659-1663
[3]  
CAMPBELL IW, 1985, HORM METAB RES, V15, P105
[4]  
Chang CT, 2002, J NEPHROL, V15, P398
[5]   IS IT TIME TO INTRODUCE METFORMIN IN THE UNITED-STATES [J].
COLWELL, JA .
DIABETES CARE, 1993, 16 (04) :653-655
[6]   METFORMIN [J].
CROFFORD, OB .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (09) :588-589
[7]  
CRYER DR, 2003, DIABETES S1, V53, pA115
[8]   Case study: Metformin-associated lactic acidosis - Could orlistat be relevant? [J].
Dawson, D ;
Conlon, C .
DIABETES CARE, 2003, 26 (08) :2471-2472
[9]   EFFICACY OF METFORMIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
DEFRONZO, RA ;
GOODMAN, AM ;
ABELOVE, W ;
REID, E ;
PITA, J ;
CALLAHAN, M ;
JOHNSON, D ;
PELAYO, E ;
PUGH, J ;
SHANK, M ;
GARZA, P ;
HAAG, B ;
KORFF, J ;
ANGELO, A ;
IZENSTEIN, B ;
VANDERLEEDEN, M ;
CATHCART, H ;
TIERNEY, M ;
BIGGS, D ;
KARAM, J ;
NOLTE, M ;
GAVIN, L ;
ELDER, MA ;
CORBOY, J ;
THWAITE, D ;
WONG, S ;
DAVIDSON, M ;
PETERS, A ;
DUNCAN, T ;
KERCHER, S ;
FISCHER, J ;
KIPNES, M ;
RADNICK, BJ ;
ROURA, M ;
ROQUE, J ;
MONTGOMERY, C ;
COLLUM, P ;
RUST, M ;
POHL, S ;
PFEIFER, M ;
ALLWEISS, P ;
LEICHTER, S ;
LEACH, P ;
GALLINA, D ;
MUSEY, V ;
BERKOWITZ, K ;
EASTMAN, R ;
TAYLOR, T ;
DELAPENA, MS ;
ZAWADSKI, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (09) :541-549
[10]   Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines [J].
Emslie-Smith, AM ;
Boyle, DIR ;
Evans, JMM ;
Sullivan, F ;
Morris, AD .
DIABETIC MEDICINE, 2001, 18 (06) :483-488